Press release
-
Press Release
Another Month, Another Milestone: Bybit Earn’s Mantle Vault More than Doubles AUM in First Quarter of 2026
DUBAI, UAE, March 26, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, announced another landmark achievement…
Read More » -
Press Release
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
78-Week Study Evaluating Subcutaneous VK2735 in Adults with Obesity and Type 2 Diabetes SAN DIEGO, March 26, 2026 /PRNewswire/ — Viking…
Read More » -
Press Release
Biozen Named Finalist in ACC 2026 Innovation Pitch Challenge
One of four companies selected to present at the American College of Cardiology Scientific Sessions in New Orleans OKLAHOMA CITY,…
Read More » -
Press Release
Benzinga Expands Global Reach With Mirae Asset Securities Relationship to Deliver U.S. Market Intelligence to Korean Investors
DETROIT and SEOUL, South Korea , March 26, 2026 /PRNewswire/ — Benzinga, the largest financial news provider in North America,…
Read More » -
Press Release
Freightos Executes Cost Optimization Plan to Support Path to Profitability
Actions align with previously communicated path to Adjusted EBITDA breakeven by the end of 2026 Continued investment in growth initiatives across…
Read More » -
Signal AI Acquires Memo to Bring First-Ever Real Readership Data into Reputation Intelligence
Signal AI is building the reputation and risk tech modern leaders need to navigate a volatile world LONDON and NEW…
Read More » -
Press Release
Boehringer Ingelheim and Connecticut Science Center Launch an Innovation Lab to Advance STEM Education Across Connecticut
Expanding access to science programming and inspiring the next generation of scientists in Connecticut Innovation Lab ribbon cutting ceremony to…
Read More » -
Press Release
Peritia Appoints Michael A. Griffith as Chief Executive Officer
Veteran life sciences executive and platform builder brings decades of biopharma leadership to accelerate growth. MORRISVILLE, N.C. and NEW YORK,…
Read More » -
Press Release
BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
GLIX1, a TET2 activator, is a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other cancers GLIX1 has demonstrated…
Read More » -
Press Release
Avoid Penalties When E-Filing W-2 and W-3 Corrections with ezW2Correction from Halfpricesoft.com.
Affordable, SSA-approved software helps businesses correct errors quickly and stay compliant before penalties increase. Available now through Amazon or Halfpricesoft.com…
Read More »








